AstraZeneca has announced a major shift in its transatlantic pricing strategy, pledging to sharply reduce the cost of its medicines in the United States following mounting political pressure. The pharmaceutical
All posts tagged in pharmaceutical investment
5Articles
The battle between the NHS and pharmaceutical giants is reaching boiling point as accusations fly over the UK’s approach to funding modern medicines. A fresh row has ignited during President
AstraZeneca, the United Kingdom’s most valuable listed business, has announced a pause on its planned £200 million expansion at the Cambridge research hub, dealing a substantial setback to the government’s
Britain is poised to miss out on billions in pharmaceutical R&D investment and access to new medicines unless urgent reforms are made to the NHS medicine rebate system, according to
Chancellor Rachel Reeves recently visited Siemens Healthineers in Oxford to present a vision for revitalising Britain’s economic growth. Highlighting the nation’s potential in areas such as artificial intelligence and life
